Clinical Trials Directory

Trials / Sponsors / Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingVK2735 for Weight Management Phase 3
Weight Loss
Phase 32025-06-23
Active Not RecruitingVK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Weight Loss
Phase 32025-06-23
CompletedVK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Weight Loss
Phase 22024-12-18
CompletedVK2735 for Weight Management Phase 2
Weight Loss
Phase 22023-08-31
CompletedPhase 1 Study to Evaluate the Safety and Tolerability of VK2735
Weight Loss, NASH
Phase 12021-12-14
CompletedA Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN
Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)
Phase 12021-06-22
CompletedA Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH
NASH - Nonalcoholic Steatohepatitis
Phase 22019-11-15
CompletedSafety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver
Hyperlipidemia, NAFLD
Phase 22016-09-28
CompletedAcute Hip Fracture Study in Patients 65 Years or Greater
Hip Fractures
Phase 22015-10-30